Abstract
MicroRNAs (miRNAs) have a major role in cancer pathogenesis, cells growth and apoptosis. We studied the dysregulation of miRNAs after the induction of apoptosis by 4 μM dose of ATO in glioblastoma cell line, U87. The anticancer effect of ATO was verified using MTT, BrdU cell proliferation assay and flow cytometric analysis. Differential expressions of 88 cancer-related miRNAs were analyzed by real-time reverse transcription PCR using miRNA PCR cancer-array system. The fold changes of miRNAs were calculated by comparing the results of treated to untreated control. Among the 88 cancer-related miRNAs, 2-fold upregulation was detected in 26 miRNAs and downregulation in 10 miRNAs compared to the control. The role of some of the miRNAs with significant changes was investigated by searching the literature and studying their roles in apoptosis, cell cycle and in various cellular signalling pathways. Our results showed that ATO modified the expression of a significant number of cancer-related miRNAs in glioblastoma cell line; most of these especially the upregulated miRNAs, were known as tumor suppressors with extensive roles in cancer associated processes and pathways. This study supports the mediatory role of miRNAs in anticancer effect of ATO.
Keywords: Apoptosis, arsenic trioxide, cancer, glioblastoma, microRNA, profiling.
Anti-Cancer Agents in Medicinal Chemistry
Title:Arsenic trioxide Alters the MicroRNA Expression Profile of U87 glioblastoma
Volume: 16 Issue: 2
Author(s): Fatemeh Shidfar, Seyed H. Ghaffari, Gholamreza Tavoosidana, Elham Hosseini, Kamran Alimoghaddam and Ardeshir Ghavamzadeh
Affiliation:
Keywords: Apoptosis, arsenic trioxide, cancer, glioblastoma, microRNA, profiling.
Abstract: MicroRNAs (miRNAs) have a major role in cancer pathogenesis, cells growth and apoptosis. We studied the dysregulation of miRNAs after the induction of apoptosis by 4 μM dose of ATO in glioblastoma cell line, U87. The anticancer effect of ATO was verified using MTT, BrdU cell proliferation assay and flow cytometric analysis. Differential expressions of 88 cancer-related miRNAs were analyzed by real-time reverse transcription PCR using miRNA PCR cancer-array system. The fold changes of miRNAs were calculated by comparing the results of treated to untreated control. Among the 88 cancer-related miRNAs, 2-fold upregulation was detected in 26 miRNAs and downregulation in 10 miRNAs compared to the control. The role of some of the miRNAs with significant changes was investigated by searching the literature and studying their roles in apoptosis, cell cycle and in various cellular signalling pathways. Our results showed that ATO modified the expression of a significant number of cancer-related miRNAs in glioblastoma cell line; most of these especially the upregulated miRNAs, were known as tumor suppressors with extensive roles in cancer associated processes and pathways. This study supports the mediatory role of miRNAs in anticancer effect of ATO.
Export Options
About this article
Cite this article as:
Shidfar Fatemeh, Ghaffari H. Seyed, Tavoosidana Gholamreza, Hosseini Elham, Alimoghaddam Kamran and Ghavamzadeh Ardeshir, Arsenic trioxide Alters the MicroRNA Expression Profile of U87 glioblastoma , Anti-Cancer Agents in Medicinal Chemistry 2016; 16 (2) . https://dx.doi.org/10.2174/1871520615666150629100752
DOI https://dx.doi.org/10.2174/1871520615666150629100752 |
Print ISSN 1871-5206 |
Publisher Name Bentham Science Publisher |
Online ISSN 1875-5992 |
Call for Papers in Thematic Issues
Induction of cell death in cancer cells by modulating telomerase activity using small molecule drugs
Telomeres are distinctive but short stretches present at the corners of chromosomes and aid in stabilizing chromosomal makeup. Resynthesis of telomeres supported by the activity of reverse transcriptase ribonucleoprotein complex telomerase. There is no any telomerase activity in human somatic cells, but the stem cells and germ cells undergone telomerase ...read more
Role of natural compounds as anti anti-cancer agents
Cancer is considered the leading cause of worldwide mortality, accounting for nearly 10 million deaths in 2022. Cancer outcome can be improved through an appropriate screening and early detection and through an efficient clinical treatment. Chemotherapy remains an important approach in treatment o f several types of cancers, even though ...read more
Signaling and enzymatic modulators in cancer treatment
Cancer accounts for nearly 10 million deaths in 2022 and is considered the leading cause of worldwide mortality. Cancer outcome can be improved through an appropriate screening and early detection and through an efficient clinical treatment. Chemotherapy, radiotherapy and surgery are the most important approach for the treatment of several ...read more
- Author Guidelines
- Graphical Abstracts
- Fabricating and Stating False Information
- Research Misconduct
- Post Publication Discussions and Corrections
- Publishing Ethics and Rectitude
- Increase Visibility of Your Article
- Archiving Policies
- Peer Review Workflow
- Order Your Article Before Print
- Promote Your Article
- Manuscript Transfer Facility
- Editorial Policies
- Allegations from Whistleblowers
Related Articles
-
Potential Gene Therapy Strategies for Cancer Stem Cells
Current Gene Therapy 68Ga/64Cu PSMA Bio-Distribution in Prostate Cancer Patients: Potential Pitfalls for Different Tracers
Current Radiopharmaceuticals 13-lncRNAs Signature to Improve Diagnostic and Prognostic Prediction of Hepatocellular Carcinoma
Combinatorial Chemistry & High Throughput Screening Overcoming Endocrine Resistance in Breast Cancer
Current Cancer Drug Targets Role of Natural Phenolic Compounds in Cancer Chemoprevention via Regulation of the Cell Cycle
Current Pharmaceutical Biotechnology Post-Translational Modifications of PTEN and their Potential Therapeutic Implications
Current Cancer Drug Targets Biologically Active Phytochemicals: A Brief Appraisal
Current Traditional Medicine Marizomib, a Proteasome Inhibitor for All Seasons: Preclinical Profile and a Framework for Clinical Trials
Current Cancer Drug Targets Multicomponent Reactions in Antimitotic Drug Discovery
Current Topics in Medicinal Chemistry Disorders of Mechanisms of Calcium Metabolism Control as Potential Risk Factors of Prostate Cancer
Current Medicinal Chemistry Non-Invasive Approaches to Visualize the Endothelin Axis In Vivo Using State-of-the-Art Molecular Imaging Modalities
Mini-Reviews in Medicinal Chemistry Expression Microarray Proteomics and the Search for Cancer Biomarkers
Current Genomics The Universal Nature, Unequal Distribution and Antioxidant Functions of Melatonin and Its Derivatives
Mini-Reviews in Medicinal Chemistry Subject Index To Volume 2
Current Women`s Health Reviews Addressing the Challenge: Current and Future Directions in Ovarian Cancer Therapy
Current Gene Therapy Natural Naphthoquinones with Great Importance in Medicinal Chemistry
Current Organic Synthesis Gemcitabine: A Critical Nucleoside for Cancer Therapy
Current Medicinal Chemistry Preclinical Evaluation of a Monoclonal Antibody (3C6) Specific for Prostate-Specific Membrane Antigen
Current Radiopharmaceuticals Drug Analogs of COX-2 Selective Inhibitors Lumiracoxib and Valdecoxib Derived from in silico Search and Optimization
Anti-Inflammatory & Anti-Allergy Agents in Medicinal Chemistry Potential Utilization of Bystander / Abscopal-Mediated Signal Transduction Events in the Treatment of Solid Tumors
Current Signal Transduction Therapy